BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34430524)

  • 1. High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection.
    Shimada S; Kamiyama T; Orimo T; Nagatsu A; Kamachi H; Taketomi A
    Hepatobiliary Surg Nutr; 2021 Aug; 10(4):454-463. PubMed ID: 34430524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
    Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
    Yu B; Zhi X; Li Q; Li T; Chen Z
    BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.
    Wakiyama S; Matsumoto M; Haruki K; Gocho T; Sakamoto T; Shiba H; Futagawa Y; Ishida Y; Yanaga K
    Anticancer Res; 2017 Jun; 37(6):3207-3213. PubMed ID: 28551666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Insulin Treatment on Prognosis of non-B non-C Hepatocellular Carcinoma After Hepatectomy.
    Amemiya H; Matsuda M; Saito R; Hosomura N; Kawaida H; Kono H; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D
    Anticancer Res; 2021 Jan; 41(1):317-326. PubMed ID: 33419826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome.
    Imura S; Shimada M; Utsunomiya T; Morine Y; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Miyake H
    Hepatogastroenterology; 2014; 61(129):129-35. PubMed ID: 24895808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma.
    Iida H; Aihara T; Ikuta S; Yamanaka N
    Oncol Lett; 2015 Oct; 10(4):2233-2238. PubMed ID: 26622825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC.
    Hiwatashi K; Ueno S; Sakoda M; Iino S; Minami K; Yamasaki Y; Okubo K; Noda M; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S
    J Cancer; 2015; 6(5):438-47. PubMed ID: 25874007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.
    Okuda Y; Mizuno S; Shiraishi T; Murata Y; Tanemura A; Azumi Y; Kuriyama N; Kishiwada M; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
    Biomed Res Int; 2014; 2014():975380. PubMed ID: 24745029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study.
    Hashimoto M; Tashiro H; Kobayashi T; Kuroda S; Hamaoka M; Ohdan H
    Int J Surg; 2017 Mar; 39():206-213. PubMed ID: 28159713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; ViganĂ² L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in patient background and prognosis after hepatectomy for hepatocellular carcinoma by hepatitis virus infection status: New trends in Japan.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Ohtsuka S; Aramaki T; Uesaka K
    Ann Gastroenterol Surg; 2021 Jul; 5(4):553-566. PubMed ID: 34337304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.
    Huo TI; Wu JC; Hsia CY; Chau GY; Lui WY; Huang YH; Lee PC; Chang FY; Lee SD
    World J Surg; 2004 Aug; 28(8):787-91. PubMed ID: 15457359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology.
    Jang W; Lee HW; Lee JS; Kim BK; Kim SU; Park JY; Ahn SH; Kim DY
    J Liver Cancer; 2022 Sep; 22(2):158-166. PubMed ID: 37383415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.